Swaminathan, M., Kantarjian, H. M., Levis, M., Guerra, V., Borthakur, G., Alvarado, Y., DiNardo, C. D., Kadia, T., Garcia-Manero, G., Ohanian, M., Daver, N., Konopleva, M., Pemmaraju, N., Ferrajoli, A., Andreeff, M., Jain, N., Estrov, Z., Jabbour, E. J., Wierda, W. G., Pierce, S., Pinsoy, M. R., Xiao, L., Ravandi, F. and Cortes, J. E. (2021) “A phase I/II study of the combination of quizartinib with azacitidine or low-dose cytarabine for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome”, Haematologica. Pavia, Italy, 106(8), pp. 2121-2130. doi: 10.3324/haematol.2020.263392.